Envision Healthcare Co. (NYSE:EVHC) – Jefferies Group increased their Q1 2018 earnings per share (EPS) estimates for shares of Envision Healthcare in a report issued on Wednesday. Jefferies Group analyst B. Tanquilut now expects that the company will post earnings of $0.62 per share for the quarter, up from their previous estimate of $0.59. Jefferies Group has a “Buy” rating and a $46.00 price target on the stock. Jefferies Group also issued estimates for Envision Healthcare’s Q2 2018 earnings at $0.75 EPS, Q3 2018 earnings at $0.86 EPS, Q4 2018 earnings at $0.96 EPS, FY2018 earnings at $3.19 EPS and FY2019 earnings at $3.70 EPS.
EVHC has been the subject of a number of other research reports. ValuEngine cut Envision Healthcare from a “buy” rating to a “hold” rating in a research note on Sunday, December 31st. Citigroup cut Envision Healthcare from a “buy” rating to a “neutral” rating and set a $31.00 price objective for the company. in a research note on Thursday, November 2nd. Mizuho set a $57.00 price objective on Envision Healthcare and gave the company a “hold” rating in a research note on Tuesday, October 31st. Cantor Fitzgerald reiterated a “hold” rating and set a $30.00 price objective on shares of Envision Healthcare in a research note on Tuesday, November 14th. Finally, SunTrust Banks set a $55.00 price objective on Envision Healthcare and gave the company a “buy” rating in a research note on Sunday, October 15th. One equities research analyst has rated the stock with a sell rating, eight have assigned a hold rating and nine have given a buy rating to the company. Envision Healthcare has an average rating of “Hold” and an average price target of $41.83.
Several hedge funds have recently bought and sold shares of EVHC. PNC Financial Services Group Inc. raised its stake in shares of Envision Healthcare by 1.5% in the second quarter. PNC Financial Services Group Inc. now owns 4,848 shares of the company’s stock worth $304,000 after purchasing an additional 70 shares during the last quarter. Stifel Financial Corp raised its stake in shares of Envision Healthcare by 28.6% in the second quarter. Stifel Financial Corp now owns 9,060 shares of the company’s stock worth $571,000 after purchasing an additional 2,016 shares during the last quarter. HighTower Advisors LLC raised its stake in shares of Envision Healthcare by 30.7% in the second quarter. HighTower Advisors LLC now owns 5,936 shares of the company’s stock worth $371,000 after purchasing an additional 1,395 shares during the last quarter. Flinton Capital Management LLC raised its stake in shares of Envision Healthcare by 18.7% in the second quarter. Flinton Capital Management LLC now owns 4,464 shares of the company’s stock worth $280,000 after purchasing an additional 704 shares during the last quarter. Finally, Bank of Nova Scotia raised its stake in shares of Envision Healthcare by 8.8% in the second quarter. Bank of Nova Scotia now owns 55,283 shares of the company’s stock worth $3,465,000 after purchasing an additional 4,487 shares during the last quarter.
TRADEMARK VIOLATION WARNING: This story was originally reported by American Banking News and is the property of of American Banking News. If you are viewing this story on another domain, it was illegally copied and republished in violation of United States and international copyright & trademark law. The legal version of this story can be accessed at https://www.americanbankingnews.com/2018/02/09/jefferies-group-equities-analysts-raise-earnings-estimates-for-envision-healthcare-co-evhc.html.
About Envision Healthcare
Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.
Receive News & Ratings for Envision Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.